[ad_1]
DUBLIN, June 29, 2022 /PRNewswire/ — The “Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report by Product (Accu-Chek Inform II, Freestyle Lite), by Region (North America, EuropeAPAC, LATAM, MEA), and Segment Forecasts, 2022-2030″ report has been added to ResearchAndMarkets.com’s offering.
The global point-of-care glucose testing market size is expected to reach USD 4.5 billion by 2030, growing at a CAGR of 4.1% over the forecast period. An increase in the demand for Point-of-Care Testing (POCT) has been witnessed in recent years.
As compared to the conventional laboratory testing performed in central lab settings, glucose POCT aids in performing effective diagnosis at the patient’s bedside. The easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings.
The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism have propelled the companies to launch innovative glucose meters in the market.
Point-of-Care Glucose Testing Market Report Highlights
- Accu-Chek Inform II accounted for the largest revenue share in 2021 and is anticipated to maintain this trend throughout the forecast period.
- Bayer Contour blood glucose monitoring system is set to grow at a CAGR of 6.1% from 2022 to 2030.
- North America is the leading regional…
Full story available on Benzinga.com
[ad_2]
Source link
